|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
simons77
|
3.4K |
1.6M |
0 |
11:10 |
| 11:10 |
ASX - By Stock
|
3.4K
|
1.6M
|
0
|
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
simons77
|
448 |
242K |
10 |
08/05/26 |
| 08/05/26 |
ASX - By Stock
|
448
|
242K
|
10
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
simons77
|
17K |
9.0M |
31 |
08/05/26 |
| 08/05/26 |
ASX - By Stock
|
17K
|
9.0M
|
31
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
simons77
|
17K |
9.0M |
19 |
08/05/26 |
| 08/05/26 |
ASX - By Stock
|
17K
|
9.0M
|
19
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
|
|
simons77
|
29 |
9.7K |
15 |
07/05/26 |
| 07/05/26 |
ASX - By Stock
|
29
|
9.7K
|
15
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
|
|
simons77
|
29 |
9.7K |
33 |
07/05/26 |
| 07/05/26 |
ASX - By Stock
|
29
|
9.7K
|
33
|
|
|
ASX - By Stock
|
SLD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
simons77
|
17 |
2.4K |
0 |
06/05/26 |
| 06/05/26 |
ASX - By Stock
|
17
|
2.4K
|
0
|
|
|
ASX - By Stock
|
OPT |
Re:
Opthea Chances as a treament for Lymphangioleiomyomatosis
|
|
simons77
|
7 |
2.8K |
0 |
06/05/26 |
| 06/05/26 |
ASX - By Stock
|
7
|
2.8K
|
0
|
|
|
ASX - By Stock
|
OPT |
Re:
Opthea Chances as a treament for Lymphangioleiomyomatosis
|
|
simons77
|
7 |
2.8K |
0 |
06/05/26 |
| 06/05/26 |
ASX - By Stock
|
7
|
2.8K
|
0
|
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Long Term Suspended Entities
|
|
simons77
|
17 |
8.0K |
0 |
06/05/26 |
| 06/05/26 |
ASX - By Stock
|
17
|
8.0K
|
0
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
simons77
|
29 |
11K |
1 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
29
|
11K
|
1
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
15 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
15
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
7 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
7
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
15 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
15
|
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Capital Consolidation Complete
|
|
simons77
|
13 |
3.2K |
4 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
13
|
3.2K
|
4
|
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
simons77
|
448 |
242K |
13 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
448
|
242K
|
13
|
|
|
ASX - By Stock
|
IMM Biotech |
Re:
IMM STOCK FOR THE YEAR
|
|
simons77
|
147 |
51K |
16 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
147
|
51K
|
16
|
|
|
ASX - By Stock
|
SLD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
simons77
|
17 |
2.4K |
0 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
17
|
2.4K
|
0
|
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Why ATX Looks More Interesting Than the Market Thinks
|
|
simons77
|
31 |
10K |
13 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
31
|
10K
|
13
|
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Why ATX Looks More Interesting Than the Market Thinks
|
|
simons77
|
31 |
10K |
4 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
31
|
10K
|
4
|
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Why ATX Looks More Interesting Than the Market Thinks
|
|
simons77
|
31 |
10K |
11 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
31
|
10K
|
11
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
simons77
|
29 |
11K |
13 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
29
|
11K
|
13
|
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 3Y Change in Director Interests - C Behrenbruch
|
|
simons77
|
12 |
4.2K |
12 |
30/04/26 |
| 30/04/26 |
ASX - By Stock
|
12
|
4.2K
|
12
|
|
|
ASX - By Stock
|
SLD |
Re:
Ann: H1 FY2026 Results Announcement
|
|
simons77
|
26 |
6.5K |
0 |
29/04/26 |
| 29/04/26 |
ASX - By Stock
|
26
|
6.5K
|
0
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Successful PARASOL Collaboration Data Analysis Outcome
|
|
simons77
|
197 |
54K |
8 |
29/04/26 |
| 29/04/26 |
ASX - By Stock
|
197
|
54K
|
8
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: ACTION3 Statistical Review Complete
|
|
simons77
|
139 |
44K |
6 |
29/04/26 |
| 29/04/26 |
ASX - By Stock
|
139
|
44K
|
6
|
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
simons77
|
3.4K |
1.6M |
0 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
3.4K
|
1.6M
|
0
|
|
|
ASX - By Stock
|
NEU |
Re:
Competitors to Daybue
|
|
simons77
|
83 |
47K |
3 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
83
|
47K
|
3
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: ACTION3 Statistical Review Complete
|
|
simons77
|
139 |
44K |
3 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
139
|
44K
|
3
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: ACTION3 Statistical Review Complete
|
|
simons77
|
139 |
44K |
17 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
139
|
44K
|
17
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: ACTION3 Statistical Review Complete
|
|
simons77
|
139 |
44K |
17 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
139
|
44K
|
17
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
9 |
27/04/26 |
| 27/04/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
9
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Upsized $14M Placement Extends Runway Post IA
|
|
simons77
|
88 |
25K |
7 |
27/04/26 |
| 27/04/26 |
ASX - By Stock
|
88
|
25K
|
7
|
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
simons77
|
448 |
242K |
14 |
27/04/26 |
| 27/04/26 |
ASX - By Stock
|
448
|
242K
|
14
|
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Why ATX Looks More Interesting Than the Market Thinks
|
|
simons77
|
31 |
10K |
18 |
27/04/26 |
| 27/04/26 |
ASX - By Stock
|
31
|
10K
|
18
|
|
|
ASX - By Stock
|
NEU |
Re:
HIE
|
|
simons77
|
36 |
18K |
9 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
36
|
18K
|
9
|
|
|
ASX - By Stock
|
QOR |
Re:
Ann: Merger Update
|
|
simons77
|
33 |
14K |
0 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
33
|
14K
|
0
|
|
|
ASX - By Stock
|
QOR |
Re:
Ann: Merger Update
|
|
simons77
|
33 |
14K |
0 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
33
|
14K
|
0
|
|
|
ASX - By Stock
|
QOR |
Re:
Ann: Merger Update
|
|
simons77
|
33 |
14K |
0 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
33
|
14K
|
0
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
3 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
3
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
3 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
3
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
6 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
6
|
|
|
ASX - By Stock
|
QOR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
simons77
|
18 |
7.3K |
2 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
18
|
7.3K
|
2
|
|
|
ASX - By Stock
|
QOR |
Re:
Ann: Merger Update
|
|
simons77
|
33 |
14K |
1 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
33
|
14K
|
1
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
simons77
|
8.9K |
3.1M |
9 |
22/04/26 |
| 22/04/26 |
ASX - By Stock
|
8.9K
|
3.1M
|
9
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: First patient dosed in Neuren PMS Phase 3 trial
|
|
simons77
|
111 |
37K |
8 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
111
|
37K
|
8
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
simons77
|
79 |
26K |
1 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
79
|
26K
|
1
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
simons77
|
79 |
26K |
9 |
10/04/26 |
| 10/04/26 |
ASX - By Stock
|
79
|
26K
|
9
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
simons77
|
79 |
26K |
4 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
79
|
26K
|
4
|
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Therapeutics Halts Recruitment in AMPLICITY Trial
|
|
simons77
|
99 |
32K |
33 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
99
|
32K
|
33
|
|